These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Radical nephrectomy and regional lymph node dissection for locally advanced type 2 papillary renal cell carcinoma in an at-risk individual from a family with hereditary leiomyomatosis and renal cell cancer: a case report. Kamai T; Abe H; Arai K; Murakami S; Sakamoto S; Kaji Y; Yoshida KI BMC Cancer; 2016 Mar; 16():232. PubMed ID: 26983443 [TBL] [Abstract][Full Text] [Related]
30. A case report of hereditary leiomyomatosis and renal cell cancer. Frey MK; Worley MJ; Heyman KP; Caputo TA Am J Obstet Gynecol; 2010 Jun; 202(6):e8-9. PubMed ID: 20510956 [TBL] [Abstract][Full Text] [Related]
31. Chromosomal abnormalities in renal cell neoplasms associated with acquired renal cystic disease. A series studied by comparative genomic hybridization and fluorescence in situ hybridization. Gronwald J; Baur AS; Holtgreve-Grez H; Jauch A; Mosimann F; Jichlinski P; Wauters JP; Cremer T; Guillou L J Pathol; 1999 Feb; 187(3):308-12. PubMed ID: 10398084 [TBL] [Abstract][Full Text] [Related]
32. Strong family history of uterine leiomyomatosis warrants fumarate hydratase mutation screening. Tolvanen J; Uimari O; Ryynänen M; Aaltonen LA; Vahteristo P Hum Reprod; 2012 Jun; 27(6):1865-9. PubMed ID: 22473397 [TBL] [Abstract][Full Text] [Related]
33. Fumarate hydratase deficient renal cell carcinoma: Chromosomal numerical aberration analysis of 12 cases. Pivovarcikova K; Martinek P; Grossmann P; Trpkov K; Alaghehbandan R; Magi-Galluzzi C; Pane Foix M; Condom Mundo E; Berney D; Gill A; Rychly B; Michalova K; Rogala J; Pitra T; Micsik T; Polivka J; Hora M; Tanas Isikci O; Skalova S; Mareckova J; Michal M; Hes O Ann Diagn Pathol; 2019 Apr; 39():63-68. PubMed ID: 30785029 [TBL] [Abstract][Full Text] [Related]
34. Evidence of increased microvessel density and activation of the hypoxia pathway in tumours from the hereditary leiomyomatosis and renal cell cancer syndrome. Pollard P; Wortham N; Barclay E; Alam A; Elia G; Manek S; Poulsom R; Tomlinson I J Pathol; 2005 Jan; 205(1):41-9. PubMed ID: 15586379 [TBL] [Abstract][Full Text] [Related]
35. Hereditary leiomyomatosis and renal cell cancer (HLRCC). Kiuru M; Launonen V Curr Mol Med; 2004 Dec; 4(8):869-75. PubMed ID: 15579034 [TBL] [Abstract][Full Text] [Related]
36. Male infertility associated with hereditary leiomyomatosis and renal cell carcinoma. McKelvey KD; Siraj S; Kelsay J; Batres F Fertil Steril; 2010 Apr; 93(6):2075.e1-2. PubMed ID: 20056206 [TBL] [Abstract][Full Text] [Related]
37. Genetic aberrations detected by comparative genomic hybridization are associated with clinical outcome in renal cell carcinoma. Moch H; Presti JC; Sauter G; Buchholz N; Jordan P; Mihatsch MJ; Waldman FM Cancer Res; 1996 Jan; 56(1):27-30. PubMed ID: 8548768 [TBL] [Abstract][Full Text] [Related]
38. Missense mutations in fumarate hydratase in multiple cutaneous and uterine leiomyomatosis and renal cell cancer. Alam NA; Olpin S; Rowan A; Kelsell D; Leigh IM; Tomlinson IP; Weaver T J Mol Diagn; 2005 Oct; 7(4):437-43. PubMed ID: 16237213 [TBL] [Abstract][Full Text] [Related]